Tripos Completes Reduction In Force For Its Discovery Research Business; Action Results In Job Losses, Primarily In The U.K.

ST. LOUIS--(BUSINESS WIRE)--Jan. 24, 2006--Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery chemistry and informatics products and services, today announced implementation of its reduction in force for its Discovery Research business. This action coincides with the conclusion of the 30-day consultation period with employees mandated by U.K. law and previously announced by Tripos on Dec. 19, 2005. The reduction in force is an integral part of Tripos’ plan to streamline and refine its Discovery Research business and associated cost structure.